SemBioSys drives value through partnerships. We recognize that our core strengths are the application of our technology and the initial development of products that improve health.
Our business strategy is to advance products through preclinical or early clinical development and then collaborate with strategic partners to support the final stages of development and successfully drive our products to market. We will partner with companies that bring key capabilities in late-stage product development, regulatory affairs, marketing and product distribution. SemBioSys’ partnering strategy will ensure our products reach the market quickly and have the greatest impact on consumer health.
SemBioSys also licenses or contracts the use of its technology as a manufacturing solution for products owned by other companies. In all instances, we structure partnerships according to a value and risk sharing model that provides near and long-term value to SemBioSys shareholders. Typical partnering transactions include upfront and success-based milestone payments and royalties that recognize the value SemBioSys has created through its products and technology.